A detailed history of Douglass Winthrop Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 41,307 shares of PFE stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
41,307
Previous 45,247 8.71%
Holding current value
$1.13 Million
Previous $1.26 Million 7.97%
% of portfolio
0.02%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $99,524 - $116,624
-3,940 Reduced 8.71%
41,307 $1.16 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $86,990 - $99,892
-3,360 Reduced 6.91%
45,247 $1.26 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $165,429 - $214,874
-6,331 Reduced 11.52%
48,607 $1.4 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $160,417 - $187,512
-4,999 Reduced 8.34%
54,938 $1.82 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $75,852 - $87,759
-2,100 Reduced 3.39%
59,937 $2.2 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $22,255 - $28,973
565 Added 0.92%
62,037 $2.53 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $15,322 - $20,001
-367 Reduced 0.59%
61,472 $3.15 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $187,748 - $222,610
4,035 Added 6.98%
61,839 $3.24 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $9,150 - $11,338
200 Added 0.35%
57,804 $2.99 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $200,195 - $296,756
4,845 Added 9.18%
57,604 $3.4 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $16,995 - $21,831
-433 Reduced 0.81%
52,759 $2.27 Million
Q2 2021

Aug 02, 2021

SELL
$35.91 - $40.68 $6,751 - $7,647
-188 Reduced 0.35%
53,192 $2.08 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $31,313 - $35,314
-935 Reduced 1.72%
53,380 $1.93 Million
Q4 2020

Jan 27, 2021

BUY
$33.47 - $42.56 $68,513 - $87,120
2,047 Added 3.92%
54,315 $2 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $18,732 - $21,977
-590 Reduced 1.12%
52,268 $1.92 Million
Q2 2020

Jul 17, 2020

BUY
$30.12 - $36.54 $160,539 - $194,758
5,330 Added 11.21%
52,858 $1.73 Million
Q1 2020

Apr 23, 2020

SELL
$27.03 - $38.62 $382,258 - $546,164
-14,142 Reduced 22.93%
47,528 $1.55 Million
Q4 2019

Jan 10, 2020

SELL
$32.92 - $37.36 $130,330 - $147,908
-3,959 Reduced 6.03%
61,670 $2.42 Million
Q3 2019

Oct 08, 2019

BUY
$32.49 - $42.13 $377,111 - $489,002
11,607 Added 21.49%
65,629 $2.36 Million
Q2 2019

Jul 10, 2019

SELL
$36.98 - $41.52 $24,961 - $28,026
-675 Reduced 1.23%
54,022 $2.34 Million
Q1 2019

Apr 09, 2019

BUY
$37.5 - $41.2 $39,787 - $43,713
1,061 Added 1.98%
54,697 $2.32 Million
Q4 2018

Jan 16, 2019

BUY
$38.47 - $43.86 $8,232 - $9,386
214 Added 0.4%
53,636 $2.34 Million
Q3 2018

Oct 12, 2018

SELL
$34.47 - $41.81 $87,105 - $105,653
-2,527 Reduced 4.52%
53,422 $2.35 Million
Q2 2018

Jul 24, 2018

BUY
$32.98 - $35.16 $149,597 - $159,485
4,536 Added 8.82%
55,949 $2.03 Million
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $331,895 - $385,045
-10,401 Reduced 16.83%
51,413 $1.83 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $188,950 - $200,482
5,681 Added 10.12%
61,814 $2.24 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.74 Million - $1.92 Million
56,133
56,133 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Douglass Winthrop Advisors, LLC Portfolio

Follow Douglass Winthrop Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.